With over 35 years of experience as a health economist specializing in the HEOR/RWE domain, David Thompson brings a wealth of expertise to clients of Rubidoux Research LLC, a company he founded in 2023. Prior to establishing Rubidoux Research, David held prominent leadership roles at several CROs and HEOR consultancies, culminating in his tenure as CEO of a large global evidence & access consultancy. David’s commitment to advancing the field is evident through his longstanding contributions to ISPOR, where he served on the board of directors, had the honor of being the founding Editor-in-Chief of Value & Outcomes Spotlight, and currently serves a Special Board Advisor. Among various other affiliations, he sits on the advisory board & work streams of selected RWE policy groups, including Duke-Margolis RWE Collaborative.